These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12202891)

  • 1. [Economic evaluation of population-based mass screening for the early detection of cancer: a systematic review].
    Muszbek N; Koncz T; V Hajdú P; Adány R
    Magy Onkol; 2002; 46(2):119-29. PubMed ID: 12202891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
    Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
    Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the most cost-effective population-based cancer screening program for Chinese women?
    Woo PP; Kim JJ; Leung GM
    J Clin Oncol; 2007 Feb; 25(6):617-24. PubMed ID: 17308266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of Leveraging Social Determinants of Health to Improve Breast, Cervical, and Colorectal Cancer Screening: A Systematic Review.
    Mohan G; Chattopadhyay S
    JAMA Oncol; 2020 Sep; 6(9):1434-1444. PubMed ID: 32556187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The state of the organized screening in Hungary in 2006].
    Kovács A; Döbrôssy L; Budai A; Cornides A; Boncz I
    Orv Hetil; 2007 Mar; 148(10):435-40. PubMed ID: 17350908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient navigation for breast and colorectal cancer in 3 community hospital settings: an economic evaluation.
    Donaldson EA; Holtgrave DR; Duffin RA; Feltner F; Funderburk W; Freeman HP
    Cancer; 2012 Oct; 118(19):4851-9. PubMed ID: 22392629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Ginsberg GM; Lauer JA; Zelle S; Baeten S; Baltussen R
    BMJ; 2012 Mar; 344():e614. PubMed ID: 22389347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of cervical cancer screening and follow-up programs.
    Celentano DD; deLissovoy G
    Public Health Rev; 1989-1990; 17(2-3):173-240. PubMed ID: 2518819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors.
    Neeser K; Szucs T; Bulliard JL; Bachmann G; Schramm W
    Value Health; 2007; 10(1):42-53. PubMed ID: 17261115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A decision-analytic evaluation of the cost-effectiveness of family history-based colorectal cancer screening programs.
    Ramsey SD; Wilschut J; Boer R; van Ballegooijen M
    Am J Gastroenterol; 2010 Aug; 105(8):1861-9. PubMed ID: 20461066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Health economics analysis of breast cancer screening].
    Boncz I; Sebestyén A; Gulácsi L; Pál M; Dózsa C
    Magy Onkol; 2003; 47(2):149-54. PubMed ID: 12975661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
    Lawson HW; Henson R; Bobo JK; Kaeser MK
    MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Health economics analysis of cervical cancer screening].
    Boncz I; Sebestyén A; Pál M; Sándor J; Ember I
    Orv Hetil; 2003 Apr; 144(15):713-7. PubMed ID: 12774432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methods to increase participation in cancer screening programmes].
    Giorgi Rossi P; Camilloni L; Cogo C; Federici A; Ferroni E; Furnari G; Giordano L; Grazzini G; Iossa A; Jimenez B; Palazzi M; Palazzo F; Spadea T; Senore C; Borgia P; Guasticchi G
    Epidemiol Prev; 2012 Jan; 36(1 Suppl 1):1-104. PubMed ID: 22418841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.
    de Gelder R; Bulliard JL; de Wolf C; Fracheboud J; Draisma G; Schopper D; de Koning HJ
    Eur J Cancer; 2009 Jan; 45(1):127-38. PubMed ID: 19038540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative economics of screening for colorectal cancer, breast cancer and cervical cancer.
    Gyrd-Hansen D
    Crit Rev Oncol Hematol; 1999 Nov; 32(2):133-44. PubMed ID: 10612013
    [No Abstract]   [Full Text] [Related]  

  • 18. The importance of age in screening for cancer.
    Law MR; Morris JK; Wald NJ
    J Med Screen; 1999; 6(1):16-20. PubMed ID: 10321365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Health economics analysis of colorectal screening].
    Boncz I; Sebestyén A; Dózsa C; Pál M; Sándor J; Palásti J; Betlehem J; Ember I
    Magy Onkol; 2004; 48(2):111-5. PubMed ID: 15351803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in Austria.
    Schiller-Fruehwirth I; Jahn B; Einzinger P; Zauner G; Urach C; Siebert U
    Value Health; 2017 Sep; 20(8):1048-1057. PubMed ID: 28964436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.